Enanta Pharmaceuticals
ENTA
#7363
Rank
A$0.67 B
Marketcap
A$23.23
Share price
5.92%
Change (1 day)
128.06%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -A$0.12 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are A$65.32 Million. In 2024 the company made an earning of -A$0.15 Billion, an increase over its 2023 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.12 Billion-18.84%
2024 -A$0.15 Billion-23.87%
2023 -A$0.2 Billion4.39%
2022 -A$0.19 Billion-4.4%
2021 -A$0.2 Billion91.12%
2020 -A$0.11 Billion-407.13%
2019 A$32.83 M-78.63%
2018 A$0.15 B117.97%
2017 A$70.5 M-574.65%
2016 -A$14.86 Million-110.83%
2015 A$0.13 B-4.5%
2014 A$0.14 B-638.53%
2013 -A$26.68 Million-137.98%
2012 A$70.22 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
A$2.50 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.90 B-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.73 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.85 B-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.12 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.78 B-21,741.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland